Search Results

Deciphering the interplay between apoptotic and signaling pathways to target T-lineage acute lymphoblastic leukemia

is an aggressive leukemia with limited treatment options. cells resist to dying by suppressing their suicide pathways. BH3 mimetics reactivate the su…

Sigurður Kristinsson

Professor Sigurður Yngvi Kristinsson is currently consolidating his position as one of the leading researchers in the field of multiple myeloma, its …

Early Detection and Intervention in Smoldering Multiple Myeloma: population-based screening and treatment; Edit-SMM

We build on the success from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) study, where over , consented to a nationwide screeni…

Nitin Jain

Nitin Jain, MD, is an Associate Professor in the Department of Leukemia at MD Anderson Cancer Center in Houston. He earned his medical degree from the…

Combination Targeted Therapy in Chronic Lymphocytic Leukemia

Targeted therapies have replaced chemoimmunotherapy in chronic lymphocytic leukemia (CLL). We previously reported that combined BTK inhibitor (ibrutin…

Nirav Shah

Nirav Shah, MD, MSHP is currently an Associate Professor of Medicine at the Medical College of Wisconsin, Division of Hematology and Oncology, special…

Improving Bispecific CD20/CD19 CAR T-cell Therapy to Overcome Resistance Mechanisms in B-cell Malignancies

The objective of this proposal is to improve bispecific / CAR activity and persistence by understanding impact of cell manufacturing parameters on fi…

Neha Mehta-Shah

Neha , MD, MSCI is an Assistant Professor of Medicine at Washington University in St. Louis where she specializes in peripheral and cutaneous lymphom…

Tycel Phillips

I am a physician employed at the University of Michigan who specializes in the management of patients with a very specific blood cancer called lymphom…

Thomas LeBlanc

I am a oncologist and palliative care physician, Associate Professor of Medicine in the Duke University School of Medicine, and member of the Duke Ca…

Patient Experience Research and Palliative Care Integration in Malignant Hematology

My research aims to improve the patient and caregiver experience of blood cancer care. To achieve this, I conduct trials of integrated palliative care…

Koichi Takahashi

Koichi Takahashi, MD, PhD is Associate Professor in the Departments of Leukemia and Genomic Medicine at The University of Texas MD Anderson Cancer Cen…

Luca Busino

The molecular mechanisms of cell proliferation and the field of Ubiquitin Proteasome System (UPS) have always been our main area of interest and fasci…

Faron Pharmaceuticals Announces the Private Placement of EUR 5 Million, Including LLS TAP

TURKU, FINLAND / BOSTON, MA, June , - Faron Pharmaceuticals Ltd (First North: FARON, AIM: FARN), a clinical stage biopharmaceutical company focused o…

Paul

I have been very active with LLS for over years including: serving on the Wisconsin Chapter Board and Leadership Development Committee; fundraising f…

Living with Myeloma

Coleman Lindsley

Dr. Lindsley is an Assistant Professor of Medicine at Harvard Medical School and Cancer Institute. He received his M.D. and Ph.D.

Genetic pathways of myeloid transformation and treatment response

Our central goal is to improve clinical outcomes in patients with myeloid malignancies through developing an enhanced mechanistic understanding of dis…

Julia Maxson

Dr. Maxson is an assistant professor in the Knight Cancer Institute, where she investigates the cellular and molecular changes that cause myeloid leuk…

Yibin Yang

I completed my Ph.D. training with Dr. Michelle Kelliher at the University of Massachusetts Medical School, studying the signal transduction pathways…